Shared on 23 Oct 25
Fair value Increased 1.11%Analysts have raised their price target for Dai-ichi Life Holdings from ¥1,346 to ¥1,361. This reflects updated assessments of the company’s fair value and modest adjustments in forecast metrics.
Shared on 20 Sep 25
Fair value Increased 1.58%Expansion In Asia And Australia Will Foster Diversification And Stability
Despite a notable decline in consensus revenue growth forecasts and a modest rise in the future P/E ratio, the consensus analyst price target for Dai-ichi Life Holdings increased marginally from ¥1325 to ¥1346. What's in the News Considering mergers and acquisitions in Southeast Asia, targeting the Philippines and Malaysia for overseas expansion.
Shared on 05 Sep 25
Expansion In Asia And Australia Will Foster Diversification And Stability
Analysts have adopted a more neutral stance on Dai-ichi Life Holdings due to reduced enterprise value and less compelling valuations, despite continued high dividend yield and stability, resulting in the consensus price target remaining unchanged at ¥1325. Analyst Commentary Lowered enterprise value at the parent company has reduced valuation appeal.
Shared on 01 May 25
Fair value Increased 13%Expansion In Asia And Australia Will Foster Diversification And Stability
Shared on 23 Apr 25
New Products And Portfolio Optimization Will Strengthen Future Prospects For Life Insurer
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Increased 7.39%New Products And Portfolio Optimization Will Strengthen Future Prospects For Life Insurer
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 7.31%New Products And Portfolio Optimization Will Strengthen Future Prospects For Life Insurer
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 6.66%New Products And Portfolio Optimization Will Strengthen Future Prospects For Life Insurer
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 6.00%New Products And Portfolio Optimization Will Strengthen Future Prospects For Life Insurer
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 7.87%New Products And Portfolio Optimization Will Strengthen Future Prospects For Life Insurer
Shared on 12 Mar 25
Fair value Increased 9.77%New Products And Portfolio Optimization Will Strengthen Future Prospects For Life Insurer
AnalystConsensusTarget has decreased revenue growth from 10.3% to 2.0% and increased profit margin from 3.5% to 4.4%.